| 摘要 |
A medicament for the treatment or prevention of diseases due to infection by Neisseria meningitidis, characterized in that it comprises glycoconjugates and/or lipooligosaccharides (LOS) included in outer membrane vesicles, blebs, lipid layers, liposomes and/or killed or commensal bacteria with cross-reactive antigens to Neisseria meningitidis of the serogroup A, B, C, H, I, K, L, X, Y, Z, 29E or W135, or non-capsulated meningococcal strains,and/or antibodies against such glycoconjugates and/or lipooligosaccharides.
|
